News
StockStory.org on MSN14h
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To KnowA number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as ...
Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.
Bausch + Lomb Corporation (NYSE/TSX ... We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
LUMIFY Preservative Free is now available in convenient single-use vials at most U.S. retailers nationwide, including Walmart, Target, CVS, Walgreens, Rite Aid and Amazon. The eye drops will have a ...
Bausch + Lomb and Walmart team up to offer free eye care clinics, samples, and education during Healthy Vision Month at 40 stores.
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
In 2023, Bausch + Lomb introduced LUMIFY EYE ILLUMINATIONS™, a line of specialty eye care products specifically developed for the sensitive area around the eyes. The FDA approved LUMIFY ...
Bausch + Lomb Corporation’s BLCO share price has surged by 7.05%, which has investors questioning if this is right time to sell.
Bausch + Lomb (NYSE: BLCO) reported mixed first quarter 2025 results, with revenue growth offset by earnings pressure from a voluntary recall of its enVista intraocular lens products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results